Tara O'Donoghue
Australia
4952 RESULTS
Australia
Germany
United Kingdom
University of Antwerp
Belgium
COMMENT Overall, this study is an important advance in molecular biomarkers for Alzheimer’s disease. I am impressed by the robustness of the YWHAG:NPTX2 ratio in the CSF and how quantitative it is as a biomarker of cognitive impairment, independent of tau/Aβ meas
The Broad Institute of MIT and Harvard
United States
UCL
United Kingdom
PAPER Arias-Aragón F, Sánchez-Hidalgo AC, Gruart A, Martinez-Mir A, Delgado-García JM, Scholl FG
PAPER Fu Y, Zhang J, Qin R, Ren Y, Zhou T, Han B, Liu B
PAPER Amato LG, Vergani AA, Lassi M, Carpaneto J, Mazzeo S, Moschini V, Burali R, Salvestrini G, Fabbiani C, Giacomucci G, Galdo G, Morinelli C, Emiliani F, Scarpino M, Padiglioni S, Nacmias B, Sorbi S, Grippo A, Bessi V, Mazzoni A
PAPER Chen H, Li N, Liu N, Zhu H, Ma C, Ye Y, Shi X, Luo G, Dong X, Tan T, Wei X, Yin H
PAPER Vanderlinden G, Radwan A, Christiaens D, Blommaert J, Sunaert S, Vandenbulcke M, Koole M, Van Laere K
PAPER Yang H, Niu L, Tian L, Hu Y, Cheng C, Li S, Le W
PAPER Sivanantharajah L, Mudher A, Shepherd D
PAPER Chaney AM, Gordon BA